Skip to content
MedsAcross

Molecule

Indium in-111 pentetate

Also known as indium in-111 pentetate disodium
Available on request
Presentations
1
Brands
1
Manufacturers
1
Available from stock
0

Indium in-111 pentetate is a radioactive diagnostic agent. It is available as injection for intrathecal use. MedsAcross supplies Indium in-111 pentetate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

US FDA first approval
18 February 1982
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Intrathecal
Dosage forms
Injection
Identifiers
UNII 7UIT3ZGC8ERxCUI 259268CAS 60662-14-8Q27268870

Clinical information

From the regulator-approved product information. Each section names its source.

Dosing overview

Extreme care must be exercised to assure aseptic conditions in intrathecal injections. The maximum recommended intrathecal dose in the average patient (70 kg) is

Source: US FDA prescribing information

Warnings and precautions

The contents of the vial are radioactive. Adequate shielding of the preparation must be maintained at all times. Since the drug is excreted by the kidneys, caution should be exercised in patients with severely impaired renal function.

Source: US FDA prescribing information

Side effects

Aseptic meningitis and pyrogenic reactions have been rarely (less than 0.4%) observed following cisternography with Pentetate lndium Disodium In 111. One death has been reported to have occurred within 20 minutes following the administration of Pentetate Indium Disodium In 111 and appears to be drug related. In addition, two cases of septic meningitis have also been reported. There have also been reports of skin reactions and vomiting following administration of Pentetate lndium Disodium In 111. Relationship of the drug to these latter occurrences has not been established.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

1 presentations of Indium in-111 pentetate, sorted by availability.

MedicineManufacturerRegisterAvailability
Indium DTPA In 111 1 mCi/mL injectionIntrathecalGE HealthcareUS FDAAvailable on request

Brands by market

1 brand names across 1 markets.

Brand names by country

United States

Manufacturers

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 18 February 1982Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Questions and answers

Is Indium in-111 pentetate available for export from India?

Yes, on request. MedsAcross lists 1 presentations of Indium in-111 pentetate and sources them for licensed hospitals, importers and physicians against valid import documents.

What brand names does Indium in-111 pentetate have?

The catalogue lists 1 brand names for Indium in-111 pentetate, including Indium DTPA In 111.

Is Indium in-111 pentetate approved by the US FDA?

Yes. The US FDA first approved Indium in-111 pentetate on 18 February 1982, according to Drugs@FDA.

Does Indium in-111 pentetate need cold chain shipping?

No listed presentation of Indium in-111 pentetate is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

References

  1. Indium DTPA In 111 prescribing information (GE Healthcare). U.S. National Library of Medicine, DailyMed. Retrieved 10 January 2024

Request Indium in-111 pentetate for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.